Your trusted destination for CME, CPD & Medical Education across the Middle East.
Sidra Medicine, Doha, Qatar
Dr. Rasha Amin, MD is a physician working in Pediatric Endocrinology at Sidra Medicine, Doha, Qatar. Her current professional work is centered on pediatric endocrine disorders, with involvement in clinical research and academic presentations. Recent publications identify her affiliation specifically with the Department of Pediatric Medicine, Division of Endocrinology, Sidra Medicine.
She is also listed as Conference Faculty for the Qatar Pediatric Endocrine and Diabetes Conference (QPEDC) 2026.
Her documented area of practice and research is Pediatric Endocrinology, including:
Her published work demonstrates involvement across several of these areas.
Dr. Amin has participated in research involving pediatric obesity and type 2 diabetes. In a 2024 study published in Cureus, she was part of a Sidra Medicine team evaluating the use of liraglutide in adolescents with obesity with or without type 2 diabetes.
She has also contributed to research concerning congenital hyperinsulinism. In a 2024 New England Journal of Medicine report, she was one of the authors describing the use of adjuvant alpelisib therapy in a patient with medically difficult-to-control congenital hyperinsulinism. A subsequent 2025 JCEM Case Reports publication further documented her work on alpelisib therapy in two patients with congenital hyperinsulinism.
Dr. Amin has presented research at the European Society for Paediatric Endocrinology (ESPE). Her 2024 ESPE abstract, “Vosoritide Therapy in Children with Achondroplasia: Single-Center Experience,” examined treatment experience with vosoritide in children with achondroplasia at Sidra Medicine.
She subsequently contributed to research presented at the 2025 joint ESE/ESPE Congress concerning a possible association between Cohen syndrome and low alkaline phosphatase, reflecting her involvement in pediatric bone and mineral metabolism and rare genetic/endocrine disorders.
Her academic work also includes diabetes associated with rare genetic syndromes. At ESPE 2024, she was an author on research examining diabetes mellitus in Woodhouse-Sakati syndrome, a rare genetic disorder with endocrine and neurological manifestations.
Her research portfolio therefore spans both common pediatric endocrine problems, such as obesity and diabetes, and rare disorders involving growth, bone metabolism, genetic syndromes and abnormal insulin regulation.
Dr. Amin has also contributed to research examining corneal nerve loss in adolescents with obesity and acanthosis nigricans. The study was published in PLOS ONE in 2024 and lists her affiliation with the Endocrinology Department at Sidra Medicine.
Dr. Amin is involved in regional and international pediatric endocrinology education. She is listed among the faculty for QPEDC 2026, the Qatar Pediatric Endocrine and Diabetes Conference.
She has also participated in international scientific meetings including ESPE 2024 and the 2025 joint ESE/ESPE Congress, presenting or co-authoring work related to pediatric endocrine and metabolic disorders.
I could not verify a reliable official source giving her medical-school name, graduation year, residency chronology, or fellowship details. The available scholarly sources consistently identify her as Rasha Amin, MD and place her in Pediatric Endocrinology at Sidra Medicine, but I would not add an unverified medical-school or training history to a MedArena profile.
That distinction is important because there are multiple physicians named Rasha Amin in Qatar and elsewhere.
Sidra Medicine
Sidra Medicine